Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
SWX:ROG
Roche Holding
|
225.10 | 32,03% | 48,13% | 181.774,36 | 4,32% | 0,43% |
|
NYSE:ABT
Abbott Laboratories
|
104.74 | 1,79% | 14,45% | 182.209,24 | 2,1% | 9,04% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
973.80 | -28,98% | -22,93% | 105.058,9 | 0% | 13,9% |
|
TSE:4568
Daiichi Sankyo Company
|
5385.00 | 0% | 0% | 10.322.749,31 | 1,15% | 0% |
|
NasdaqGS:INCY
Incyte
|
53.06 | 104,81% | 153,29% | 12.012,93 | 0% | 27,62% |
|
NasdaqGS:EXEL
Exelixis
|
21.37 | 39,15% | 69,39% | 6.338,53 | 0% | -8,84% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
39.08 | -.156,68% | -.149,23% | 5.756,54 | 0% | 0% |
|
NasdaqGS:ALKS
Alkermes
|
24.05 | 179,13% | 204,47% | 4.105,31 | 0% | 18,74% |
|
NasdaqGM:SUPN
Supernus Pharmaceuticals
|
28.96 | 2,87% | 17,34% | 1.720,68 | 0% | -11,07% |
|
NasdaqGM:RVNC
Revance Therapeutics
|
3.32 | 0% | 0% | 447,08 | 0% | 0% |
|
NasdaqGS:PBYI
Puma Biotechnology
|
4.81 | -31,2% | -32,97% | 232,99 | 0% | 189,4% |
|
NasdaqCM:ASRT
Assertio Holdings
|
0.96 | -.100% | -52,24% | 100,36 | 0% | -35,38% |
